The entrepreneur: a new breed of health service leader?

2008 ◽  
Vol 22 (3) ◽  
pp. 208-222 ◽  
Author(s):  
Rosemary Exton
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Power Structures ◽  
Content Type ◽  
Working Lives ◽  
Service Leader ◽  
Private And Public ◽  
Uk National Health Service ◽  
The Uk

PurposeThis paper aims to critically examine the notion of entrepreneurship in the UK National Health Service (NHS), promoted by government ministers and senior civil servants as part of the rhetoric of the modernisation agenda.Design/methodology/approachThe paper explores literature on entrepreneurship in the private and public sector and qualitative case study evidence on the emergence (and non‐emergence) of “entrepreneurs” who led the improving working lives (IWL) initiative in the UK National Health Service and discusses the issues involved.FindingsThe rhetoric serves an essentially ideological function, obscuring the real difficulty of securing effective and sustainable change, in organisations with deeply engrained power structures and as complex and intransient as the NHS in particular and health services more generally.Practical implicationsA “new breed of entrepreneurial leaders” may eventually appear but they face the challenge of surviving in the hierarchical NHS culture and in a climate of turbulent change created by the volatility of government policy.Originality/valueThe paper shows that efforts to pursue entrepreneurship in the UK NHS have to overcome obstacles involving the interplay of power, gender and language.

National trends and cost of litigation in UK National Health Service (NHS): a specialty-specific analysis from the past decade

2021 ◽  
Vol 66 (4) ◽  
pp. 168-174
Author(s):  
Jenni Lane ◽  
Rahul Bhome ◽  
Bhaskar Somani
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Financial Burden ◽  
Total Annual Cost ◽  
Legal Reforms ◽  
Specific Analysis ◽  
Uk National Health Service ◽  
The Uk ◽  
National Trends

Background and aims Medical litigation claim and costs in UK are rising. This study aims to analyse the 10-year trend in litigation costs for individual clinical specialties in the UK from 2009/10 to 2018/19. Methods Data were procured from National Health Service (NHS) Resolution. Number of claims, total litigation costs and cost per claim were ascertained for each financial year. The data collected also includes the number of claims and average amount per claim per speciality during the years 2009–2019 (2009/2010 to 2018/2019 financial years). Results The total annual cost of NHS litigation is currently £3.6 billion(2018/2019). Damages make up the greatest proportion of costs(£1.5 billion). Surgical specialties have the greatest number of claims annually(2847) but Obstetrics has the greatest total litigation(£1.9 billion) and cost per claim(£2.6 million). Number of claims, total costs and cost per claim are significantly greater in 2018/2019 than in 2009/2010. Conclusions Addressing the issue of litigations is complex. Medically there are speciality specific issues that require attention, whilst some general measures are common to all: effective communication, setting realistic targets and maintaining a motivated, adequately staffed workforce. These, alongside legal reforms, may reduce the financial burden of increasing litigation on the NHS.

scholarly journals Pharmacogenomics in the UK National Health Service: opportunities and challenges

2020 ◽  
Vol 21 (17) ◽  
pp. 1237-1246
Author(s):  
Richard M Turner ◽  
William G Newman ◽  
Elvira Bramon ◽  
Christine J McNamee ◽  
Wai Lup Wong ◽  
...  
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Genomic Medicine ◽  
Improve Patient Care ◽  
Healthcare Sector ◽  
Patient Representatives ◽  
To Come ◽  
Uk National Health Service ◽  
The Uk

Despite increasing interest in pharmacogenomics, and the potential benefits to improve patient care, implementation into clinical practice has not been widespread. Recently, there has been a drive to implement genomic medicine into the UK National Health Service (NHS), largely spurred on by the success of the 100,000 Genomes Project. The UK Pharmacogenetics and Stratified Medicine Network, NHS England and Genomics England invited experts from academia, the healthcare sector, industry and patient representatives to come together to discuss the opportunities and challenges of implementing pharmacogenomics into the NHS. This report highlights the discussions of the workshop to provide an overview of the issues that need to be considered to enable pharmacogenomic medicine to become mainstream within the NHS.

Sign in / Sign up

Export Citation Format

Share Document